MAPT and Alzheimer disease: It is, however, worth noting that whereas the MC1 epitope is an early marker of tau pathology in AD, as well as in FTLD patients [58] and model mice [59], this association by no means demonstrates a pathologically causal role of the MC1-positive conformation.